CELL THERAPY BASED ON IMPROVED NATURAL KILLER CELLS Russian patent published in 2022 - IPC A61K35/17 A61K39/395 A61P35/00 A61P35/02

Abstract RU 2776890 C2

FIELD: cell biology; medicine.

SUBSTANCE: present invention relates to cell biology and medicine, in particular to a combination of natural killer cells (hereinafter – NK) or a line of NK cells, providing a cytotoxic effect, with an antibody-antagonist relatively to IL-6R and a method for the treatment of blood cancer, the cells of which express IL-6R, using the specified combination.

EFFECT: present invention allows for the improvement of efficiency and improvement of therapy of blood cancer, the cells of which express IL-6R.

51 cl, 70 dwg, 1 tbl, 11 ex

Similar patents RU2776890C2

Title	Year	Author	Number
MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES WITH INCREASED CYTOTOXICITY	2016	O`Dvajer, Majkl Imon Piter	RU2772348C2
METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS	2005	Godovski Pol Dzh. Satial Sandzhiv Kh.	RU2395294C2
ANALYSES AND METHODS WITH APPLICATION OF BIOMARKERS	2005	Vagner Klaus V.	RU2431676C2
ANALYSES AND METHODS USING BIOMARKERS	2005	Vagner Klaus V.	RU2410438C2
METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE	2019	Shpall, Elizabeth Rezvani, Katy	RU2814083C2
PHARMACEUTICAL COMPOSITION POSSESSING ANTITUMOUR EFFECT, AND METHOD FOR REDUCING PD-L1 INHIBITING EFFECT ON HUMAN T-CELLS	2016	Wu Zhao	RU2688692C2
ANALYSES AND METHODS OF BIOMARKER APPLICATION	2006	Vagner Klaus V. Ashkenazi Avi Dzh.	RU2409817C2
CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS	2018	Davila, Marko L.	RU2800922C2
APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES	2006	Vagner Klaus V. Ashkenazi Avi Dzh.	RU2416097C2
COMPOSITIONS AND METHODS OF IMMUNOTHERAPY	2014	Brentdzhens Rener Dzh. Dzhekson Kholli Dzh.	RU2680010C2

RU 2 776 890 C2

Authors

O Dvajer, Majkl Imon Piter

Khu, Dzhinson

Dates

2022-07-28—Published

2017-12-11—Filed